HCA
HCA Healthcare, Inc. · Healthcare · Medical Care Facilities
At close
$358.57
−$8.78 (−2.39%) Close
Pre-market $360.00 +$1.43 (+0.40%) 12:22 AM ET
Prev close $367.35
Open $361.59
Day high $363.16
Day low $357.09
Volume 14,867
Avg vol 1,525,004
Mkt cap
$81.49B
P/E ratio
12.35
FY Revenue
$76.39B
EPS
29.04
Gross Margin
100.00%
Sector
Healthcare
AI report sections
HCA
HCA Healthcare, Inc.
HCA combines solid multi-period price appreciation and positive momentum signals with overbought technical readings and a stretched position versus key moving averages. Fundamentally, the company shows steady revenue, earnings, and cash flow growth with healthy margins and free cash flow generation but operates with very high leverage, minimal equity, and tight liquidity ratios. Valuation appears moderate on earnings and cash flow metrics while the balance sheet structure and elevated short-volume activity introduce non-trivial risk considerations.
AI summarized at 10:51 AM ET, 2026-01-27
AI summary scores
INTRADAY: 63 SWING: 71 LONG: 77
Volume vs average
Intraday (cumulative)
+50% (Above avg)
Vol/Avg: 1.50×
RSI
17.68 (Oversold)
Oversold (<30)
MACD momentum
Intraday
+0.24 (Strong)
MACD: 0.52 Signal: 0.27
Short-Term
-2.07 (Weak)
MACD: -21.05 Signal: -18.98
Long-Term
-2.88 (Weak)
MACD: -34.31 Signal: -31.42
Intraday trend score 43.51

Latest news

HCA 12 articles Positive: 6 Neutral: 4 Negative: 2
Positive The Motley Fool • Prosper Junior Bakiny
3 Beaten-Down Stocks to Buy and Hold Forever

Despite recent declines, three healthcare stocks—Intuitive Surgical, HCA Healthcare, and Abbott Laboratories—are positioned as long-term buy-and-hold opportunities. While facing macroeconomic headwinds and near-term challenges, each company has strong underlying fundamentals, innovative products, and exposure to growing healthcare trends that could drive significant long-term returns.

ISRG HCA ABT healthcare stocks robotic-assisted surgery hospital chains medical devices dividend stocks
Sentiment note

Declined 21% year-to-date amid high expenses, but company has successfully navigated similar challenges before. Strong market position as leading U.S. hospital chain with entrenched community relationships and 15-year track record of gaining market share positions it well for long-term growth from aging population trends.

Neutral GlobeNewswire Inc. • Michael French
Awareness is Key: 3 Steps to Help Recognize Stroke Signs and Risks for Better Outcomes

The American Heart Association highlights that strokes affect approximately 800,000 Americans annually and occur every 40 seconds. However, about 80% of strokes are preventable through lifestyle choices and risk factor management. The article emphasizes the importance of recognizing warning signs using the B.E. F.A.S.T. acronym and seeking immediate emergency care, as early treatment significantly improves survival rates and reduces disability.

HCA stroke prevention B.E. F.A.S.T. warning signs brain health blood pressure management emergency response risk factors
Sentiment note

HCA Healthcare is mentioned only as the employer of Dr. Adrian Jaquin-Valdivia, a stroke neurologist providing expert commentary. The mention is purely informational with no direct business implications or performance-related content.

Neutral Benzinga • Vandana Singh
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

Tenet Healthcare reported mixed Q1 2026 results with adjusted EPS of $4.82 beating consensus of $4.18, but sales of $5.37B missed expectations of $5.39B. The company blamed unfavorable payer mix from lower exchange admissions and winter storms for soft performance. Despite this, Tenet raised full-year adjusted earnings guidance to $16.38-$18.68 per share and reaffirmed sales guidance of $21.5-$22.3B. The stock declined 5.95% on the news.

THC HCA Q1 earnings hospital operator payer mix admissions guidance raised cash flow
Sentiment note

Mentioned briefly in a related article noting soft respiratory season and volume lags. Q1 2026 revenue grew 4.3% YoY to $19.11B with adjusted EPS of $7.15, but the company is flagging operational headwinds similar to Tenet, suggesting industry-wide challenges in the hospital sector.

Negative Benzinga • Vandana Singh
Hospital Operator HCA Healthcare Flags Soft Respiratory Season As Volumes Lag

HCA Healthcare reported Q1 2026 earnings of $7.15 per share, in line with consensus, but shares fell 9.08% due to weak volume metrics. The company experienced a soft respiratory season with respiratory admissions down 42% and ER visits down 32% year-over-year, along with winter storm impacts. Despite reaffirming 2026 guidance, same-facility metrics showed mixed trends with modest admission growth offset by declining surgeries.

HCA HCA Healthcare Q1 2026 earnings hospital operator respiratory season volume decline guidance reaffirmed stock decline
Sentiment note

Stock declined 9.08% despite meeting earnings consensus. The primary driver is weak volume growth due to lower respiratory activity (down 42% in admissions, 32% in ER visits) and winter weather impacts. Mixed same-facility metrics with declining surgeries and modest admission growth, combined with guidance that trails consensus expectations on sales ($76.5-80B vs $78.68B consensus), indicate operational headwinds despite reaffirmed guidance.

Negative Benzinga • Piero Cingari
Nasdaq 100 Marks Fresh Records, Intel Jumps 23% On AI Chip Mania: Stock Market Today

The Nasdaq 100 reached fresh record highs on Friday, driven by Intel's blockbuster earnings beat that sparked a broad semiconductor rally. Intel surged 22.6% after exceeding revenue and profit forecasts, benefiting from AI server demand. The S&P 500 rose 0.7% while the Dow slipped 0.1%. Tech stocks led gains, with semiconductor ETFs posting their 18th consecutive day of gains. However, Charter Communications collapsed 23% on a subscriber miss, dragging down cable peers.

INTC NVDA AMD QCOM Intel earnings AI chip demand semiconductor rally Nasdaq 100 record
Sentiment note

Declined as healthcare sector lagged, with HCA missing earnings expectations.

Neutral GlobeNewswire Inc. • Not Specified
Frist Art Museum Presents Exhibition Exploring Surrealism Featuring Salvador Dalí, René Magritte, Joan Miró, Dorothea Tanning, and Many Others

The Frist Art Museum in Nashville will present 'International Surrealism from Tate: Fifty Years of Dreams,' an exhibition featuring approximately 125 works by renowned surrealist artists including Salvador Dalí, René Magritte, and Joan Miró. Running from May 22 through August 30, 2026, the exhibition explores surrealism's global influence and its themes of personal freedom, political resistance, and artistic innovation through paintings, sculptures, photographs, and archival materials.

HCA surrealism Frist Art Museum Tate collection Salvador Dalí René Magritte Joan Miró art exhibition
Sentiment note

Mentioned as Platinum Sponsor of the exhibition. This is a standard corporate sponsorship arrangement with no positive or negative implications beyond typical business support for cultural institutions.

Neutral GlobeNewswire Inc. • Na
Big Sky Asset Management Acquires Healthcare Facility in Denton, Texas commencing Partnership with Clarion Partners

Big Sky Asset Management and Clarion Partners completed the acquisition of a 38,000-square-foot inpatient rehabilitation facility in Denton, Texas, leased to Baylor Scott & White Health under a long-term triple-net lease. The transaction marks Big Sky's first deal with Clarion Partners and represents the firm's fifth acquisition totaling over $100 million in the last 90 days, further expanding its healthcare real estate portfolio in the high-growth Dallas-Fort Worth market.

HCA healthcare real estate inpatient rehabilitation facility Denton Texas triple-net lease acquisition Dallas-Fort Worth Baylor Scott & White Health
Sentiment note

HCA Healthcare operates the adjacent Medical City Denton hospital, which provides strategic value to the acquired facility through proximity and complementary services. However, HCA is mentioned only contextually as a neighboring operator without direct involvement in this transaction.

Positive Investing.com • Nathan Reiff
HCA Healthcare Could Be a Long-Term Winner as America Ages

HCA Healthcare is positioned as a long-term investment opportunity as America's aging population drives increased healthcare demand. The company reported strong Q4 2025 earnings with 19 consecutive quarters of volume growth and 11% YOY adjusted EBITDA growth, though revenue slightly missed expectations. Management provided optimistic 2026 guidance with expected revenue of $76.5-$80 billion and EPS of $29.10-$31.50, supported by a $10 billion share repurchase program and dividend increase. However, the company faces headwinds from health insurance exchange changes and state supplemental payment declines totaling $850 million to $1.35 billion.

HCA aging population healthcare demand earnings growth volume growth EBITDA capital expenditure share repurchase
Sentiment note

Strong operational performance with 19 consecutive quarters of volume growth, 11% YOY EBITDA growth, record patient encounters (47 million), and optimistic 2026 guidance. Management is investing heavily in growth ($5.5B CapEx) while returning capital to shareholders ($10B buyback, 8.3% dividend increase). Two-thirds of analysts rate it Buy, and the company is well-positioned to benefit from demographic trends, though near-term upside may be limited after 14% YTD appreciation.

Positive The Motley Fool • Jonathan Ponciano
This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year

Abdiel Capital Advisors sold 1,075,738 shares of Appian (worth $38.32 million) in Q4 2025, reducing its stake to 12.4% of assets. Appian shares have fallen 28.1% over the past year and underperformed the S&P 500 by 39.1 percentage points. Despite the reduction, Abdiel maintains a double-digit allocation, suggesting risk management rather than abandonment of the investment thesis.

APPN HCA GLBE AFRM fund selling stock decline low-code automation enterprise software
Sentiment note

Listed as Abdiel Capital's top holding at 44.2% of AUM ($31.39 million), indicating strong confidence and allocation priority within the fund's portfolio.

Positive The Motley Fool • Prosper Junior Bakiny
1 Unstoppable Healthcare Stock to Buy and Hold

HCA Healthcare, a major medical facilities operator, delivered strong Q4 2025 results with 6.7% revenue growth and 28.8% EPS growth. Despite modest 3.5% revenue guidance for 2026 due to expired premium tax credits and regulatory uncertainty, the company is well-positioned for long-term growth driven by aging populations and AI-enhanced healthcare initiatives.

HCA healthcare stocks HCA Healthcare medical facilities earnings growth regulatory uncertainty aging population artificial intelligence in healthcare
Sentiment note

Strong Q4 2025 financial performance with 6.7% revenue growth and 28.8% EPS jump. Stock up 7% YTD in 2026. Company demonstrates resilience amid regulatory challenges and has significant long-term growth opportunities from aging populations and AI-driven initiatives. Analyst recommends holding for long-term above-average returns despite near-term volatility.

Positive The Motley Fool • Prosper Junior Bakiny
2 High-Flying Growth Stocks to Buy and Hold for 10 Years

The article recommends Robinhood Markets and HCA Healthcare as strong 10-year investment opportunities. Robinhood is positioned to benefit from its popularity among younger investors and expanding services including AI tools and prediction markets, despite valuation concerns and crypto volatility. HCA Healthcare is well-positioned to capitalize on demographic shifts as the aging population increases healthcare demand, with a diversified payer mix helping mitigate reimbursement risks.

HOOD HCA growth stocks long-term investing commission-free trading cryptocurrency healthcare demographic shift
Sentiment note

Well-positioned to benefit from aging U.S. population increasing healthcare demand through 2036; demonstrated ability to grow market share over 15 years; diversified payer mix reduces reimbursement risk; strong 2025 performance with higher service utilization and favorable reimbursement rates.

Positive Benzinga • Eva Mathew
OpenAI Buys Healthcare Startup Torch Days After Launching ChatGPT Health

OpenAI acquired healthcare startup Torch for approximately $60-100 million, days after launching ChatGPT Health. Torch was designed as a unified medical memory platform consolidating patient data from hospitals, labs, and wearables. The four-person team will join OpenAI as part of the acquisition. This move is part of OpenAI's broader expansion into healthcare with enterprise-grade products for health systems like HCA Healthcare.

HCA OpenAI Torch acquisition ChatGPT Health healthcare technology medical data AI in healthcare HCA Healthcare
Sentiment note

HCA Healthcare is mentioned as an initial partner for OpenAI's healthcare products, positioning the company to benefit from advanced AI-powered healthcare solutions and potentially improving operational efficiency.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal